Background: Diagnosis and immunotherapy of house-dust mite (HDM) allergy is still based on natural allergen extracts. The aim of this study was to analyze commercially available Dermatophagoides pteronyssinus extracts from different manufacturers regarding allergen composition and content and whether variations may affect their allergenic activity. Methods: Antibodies specific for several D. pteronyssinus allergens (Der p 1, 2, 5, 7, 10 and 21) were used to analyze extracts from 10 different manufacturers by immunoblotting. Sandwich ELISAs were used to quantify Der p 1 and Der p 2 in the extracts. Mite-allergic patients (n = 45) were skin-tested with the extracts and tested for immunoglobulin E (IgE) reactivity to a panel of 10 mite allergens (Der p 1, 2, 4, 5, 7, 8, 10, 14, 20 and 21) by dot blot. Results: Only Der p 1 and Der p 2 were detected in all extracts but their concentrations and ratios showed high variability (Der p 1: 6.0–40.8 µg ml–1; Der p 2: 1.7–45.0 µg ml–1). At least 1 out of 4 allergens (i.e. Der p 5, 7, 10 and 21) was not detected in 8 of the studied extracts. Mite-allergic subjects showed different IgE reactivity profiles to the individual mite allergens, the extracts showed different allergenic activity in skin-prick tests and false-negative results. Conclusions: Commercially available D. pteronyssinus extracts lack important allergens, show great variability regarding allergen composition and content and some gave false-negative diagnostic test results in certain patients.

1.
Kern RA: Dust sensitization in bronchial asthma. Med Clin North Am 1921;5:751–758.
2.
Voorhorst R, Spieksma-Boezman MIA, Spieksma FTHM: Is a mite (Dermatophagoides spp.) the producer of the house dust allergen? Allerg Asthma 1964;10:329–334.
3.
Tovey ER, Chapman MD, Platts-Mills TA: Mite faeces are a major source of house dust allergens. Nature 1981;289:592–593.
4.
Thomas WR, Heinrich TK, Smith WA, Hales BJ: Pyroglyphid house dust mite allergens. Protein Pept Lett 2007;14:943–953.
5.
Weghofer M, Dall’Antonia Y, Grote M, Stöcklinger A, Kneidinger M, Balic N, Krauth MT, Fernandez-Caldas E, Thomas WR, van Hage M, Vieths S, Spitzauer S, Horak F, Svergun DI, Konarev PV, Valent P, Thalhamer J, Keller W, Valenta R, Vrtala S: Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy 2008;63:758–767.
6.
Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology: Position paper: skin tests used in type I allergy testing. Allergy 1989;44:1–59.
7.
The European Academy of Allergology and Clinical Immunology: Position paper: allergen standardization and skin tests. Allergy 1993;48:48–82.
8.
Board of Directors of the American Academy of Allergy, Asthma and Immunology: Position statement: allergen skin testing. J Allergy Clin Immunol 1993;92:636–637.
9.
Reed CE, Yunginger JW, Evans R: Quality assurance and standardization of allergy extracts in allergy practice. J Allergy Clin Immunol 1989;84:4–8.
10.
Larenas-Linnemann D, Cox LS, Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology: European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008;100:137–145.
11.
Vogel L, Lüttkopf D, Hatahet D, Vieths S: Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 2005;60:1021–1028.
12.
Hoffmann A, Jamin A, Foetisch K, May S, Aulepp H, Haustein D, Vieths S: Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of beta-hexosaminidase release from RBL-2H3 cells. Comparison with classical methods in allergen standardization. Allergy 1999;54:446–454.
13.
Larsen JN, Dreborg S: Standardization of allergen extracts. Methods Mol Med 2008;138:133–145.
14.
Dreborg S, Einarsson R: The major allergen content of allergenic preparations reflect their biological activity. Allergy 1992;47:418–423.
15.
van Ree R: Indoor allergens: relevance of major allergen measurements and standardization. J Allergy Clin Immunol 2007;119:270–277.
16.
Van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al: The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008;63:310–326.
17.
Eraso E, Martinez J, Garcia-Ortega P, Martinez A, Palacios R, Cisterna R, Guisantes JA: Influence of mite growth culture phases on the biological standardisation of allergenic extracts. J Investig Allergol Clin Immunol 1998;8:201–206.
18.
Maasch HJ, Wahl R, Fuchs T: Application of the first international standard of Dermatophagoides pteronyssinus (house dust mite) in the evaluation of allergen extracts produced from two different source materials. Int Arch Allergy Appl Immunol 1987;84:363–372.
19.
Tovey ER, Baldo BA: Comparison by electroblotting of IgE-binding components in extracts of house dust mite bodies and spent mite culture. J Allergy Clin Immunol 1987;79:93–102.
20.
Esch RE: Allergen source materials and quality control of allergenic extracts. Methods 1997;13:2–13.
21.
Brunetto B, Tinghino R, Braschi MC, Antonicelli L, Pini C, Iacovacci P: Characterization and comparison of commercially available mite extracts for in vivo diagnosis. Allergy 2010;65:184–190.
22.
Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, Horak F, Grönlund H, van Hage M, Valenta R, Vrtala S: Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008;12:959–965.
23.
Hales BJ, Shen HD, Thomas WR: Cytokine responses to Der p 1 and Der p 7: house dust mite allergens with different IgE-binding activities. Clin Exp Allergy 2000;30:934–943.
24.
Mills KL, Hart BJ, Lynch NR, Thomas WR, Smith W: Molecular characterization of the Group 4 house dust mite allergen from Dermatophagoides pteronyssinus and its amylase homologue from Euroglyphus maynei. Int Arch Allergy Immunol 1999;120:100–107.
25.
Weghofer M, Grote M, Dall’Antonia Y, Fernández-Caldas E, Krauth M-T, van Hage M, Horak F, Thomas WR, Valent P, Keller W, Valenta R, Vrtala S: Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy. Int Arch Allergy Immunol 2008;147:101–109.
26.
Resch Y, Weghofer M, Seiberler S, Horak F, Scheiblhofer S, Linhart B, et al: Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy 2011;41:1468–1477.
27.
Chen KW, Fuchs G, Sonneck K, Gieras A, Swoboda I, Douladiris N, Linhart B, Jankovic M, Pavkov T, Keller W, Papadopoulos NG, Valent P, Valenta R, Vrtala S: Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering. Mol Immunol 2008;45:2486–2498.
28.
Epton MJ, Dilworth RJ, Smith W, Thomas WR: Sensitisation to the lipid-binding apolipophorin Der p 14 and the peptide Mag-1. Int Arch Allergy Immunol 2001;124:57–60.
29.
Mari A, Di Felice G, Afferni C, Barletta B, Tinghino R, Sallusto F, Pini C: Assessment of skin prick test and serum specific IgE detection in the diagnosis of Cupressaceae pollinosis. J Allergy Clin Immunol 1996;98:21–31.
30.
Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996;68:850–858.
31.
Vrtala S, Focke M, Kopec J, Verdino P, Hartl A, Sperr WR, Fedorov AA, Ball T, Almo S, Valent P, Thalhamer J, Keller W, Valenta R: Genetic engineering of the major Timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity. J Immunol 2007;179:1730–1739.
32.
Meyer CH, Bond JF, Chen MS, Kasaian MT: Comparison of the levels of the major allergens Der p I and Der p II in standardized extracts of the house dust mite, Dermatophagoides pteronyssinus. Clin Exp Allergy 1994;24:1041–1048.
33.
Asturias JA, Ibarrola I, Arilla MC, Vidal C, Ferrer A, Gamboa PM, Vinuela JE, Sanz ML, Andrei C, Martinez A: Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. Clin Exp Allergy 2009;39:1088–1098.
34.
Lynch NR, Thomas WR, Garcia NM, Di Prisco MC, Puccio FA, Lopez RI, Hazell LA, Shen HD, Lin KL, Chua KY: Biological activity of recombinant Der p 2, Der p 5 and Der p 7 allergens of the house dust mite Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 1997;114:59–67.
35.
Asturias JA, Arilla MC, Gomez-Bayon N, Martinez A, Martinez J, Palacios R: Sequencing and high level expression in Escherichia coli of the tropomyosin allergen (Der p 10) from Dermatophagoides pteronyssinus. Biochim Biophys Acta 1998;1397:27–30.
36.
Van der Veen MJ, Jansen HM, Aalberse RC, van der Zee JS: Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response. Clin Exp Allergy 2001;31:705–714.
37.
Nielsen NH, Dirksen A, Mosbech H, Launbjerg J, Biering I, Søborg M: Skin prick testing with standardized extracts from 3 different manufacturers. A comparative randomized study. Allergol Immunopathol 1992;20:246–248.
38.
Eichler I, Götz M, Jarisch R, Eichler HG, Moss R: Reproducibility of skin prick testing with allergen extracts from different manufacturers. Allergy 1988;43:458–463.
39.
Focke M, Marth K, Flicker S, Valenta R: Heterogeneity of commercial Timothy grass pollen extracts. Clin Exp Allergy 2008;38:1400–1408.
40.
Focke M, Marth K, Valenta R: Molecular composition and biological activity of commercial birch pollen allergen extracts. Eur J Clin Invest 2009;39:429–436.
41.
Lundberg M, Chen Z, Rihs HP, Wrangsjö K: Recombinant spiked allergen extract. Allergy 2001;56:794–795.
42.
Westritschnig K, Horak F, Swoboda I, Balic N, Spitzauer S, Kundi M, Fiebig H, Suck R, Cromwell O, Valenta R: Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest 2008;38:260–267.
43.
Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O: Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608–613.
44.
Linhart B, Hartl A, Jahn-Schmid B, Verdino P, Keller W, Krauth MT, Valent P, Horak F, Wiedermann U, Thalhamer J, Ebner C, Kraft D, Valenta R: A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol 2005;115:1010–1016.
45.
Metz-Favre C, Linhart B, Focke-Tejkl M, Purohit A, de Blay F, Valenta R, Pauli G: Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule. J Allergy Clin Immunol 2007;120:315–321.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.